Brazil undertakes review of breast cancer screening
This article was originally published in Clinica
Brazil has reported a 73% rise in the number of mammography tests performed annually over the last five years. In 2001, 1.4 million tests were performed, compared with 810,000 in 1997 and 590,000 in 1995. Last year, Brazil spent R$44.54 million ($19.4 million) on mammography screening, compared with R$16.49 million in 1997. The national health service - Sistema Unico de Saude (SUS) - currently operates 792 mammography units in 784 hospitals, compared with 455 units in 1997, and 396 in 1995. During the last three years, the SUS has acquired 93 new mammography units. Brazil's cancer screening and treatment services are also being extended most significantly under an ongoing oncology network development project (see Clinica No 997, p 14).
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.